Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

123

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01XA02	KARBOTEEN	G	Carboplatin - 150mg/15ml	150mg/15ml	Injectable solution	2,080,268 L.L
L01XA02	CARBOPLATINE VIATRIS 10MG/ML	G	Carboplatin - 50mg/5ml	50mg/5ml	Injectable solution	941,930 L.L
L01XA03	OXALIPLATIN HOSPIRA	G	Oxaliplatin - 100mg/20ml	5mg/ml	Injectable concentrated solution	8,471,583 L.L
L01XA03	OXALIPLATIN MEDAC	G	Oxaliplatin - 100mg	100mg	Injectable powder for solution	7,841,801 L.L
L01XA03	OXALIPLATINE VIATRIS 5MG/ML	G	Oxaliplatin - 100mg	100mg	Injectable powder for solution	6,976,204 L.L
L01XA03	OXALIPLATINO GP PHARM	G	Oxaliplatin - 100mg	100mg	Injectable lyophilised powder for solution	6,197,802 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 100mg	100mg	Injectable lyophilised powder for solution	5,915,595 L.L
L01XA03	ELOXATIN	B	Oxaliplatin - 50mg/10ml	50mg/10ml	Injectable concentrated solution	4,930,558 L.L
L01XA03	OXALIPLATIN EBEWE	G	Oxaliplatin - 50mg/10ml	50mg/10ml	Injectable concentrated solution	3,405,297 L.L
L01XA03	OXALIPLATIN HOSPIRA	G	Oxaliplatin - 50mg/10ml	5mg/ml	Injectable concentrated solution	3,450,988 L.L
L01XA03	OXALIPLATIN MEDAC	G	Oxaliplatin - 50mg	50mg	Injectable powder for solution	3,440,237 L.L
L01XA03	OXALIPLATINE VIATRIS 5MG/ML	G	Oxaliplatin - 50mg	50mg	Injectable powder for solution	4,428,565 L.L
L01XA03	OXALIPLATINO GP PHARM	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder for solution	2,956,454 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder for solution	2,957,797 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder	2,957,797 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	L.L
L01XG01	VELCADE	B	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	23,616,000 L.L
L01XG01	ALVOCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	14,169,600 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	11,020,381 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	11,020,381 L.L
L01XG01	BORTEZOMIB ACCORD	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	13,007,658 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	14,169,600 L.L
L01XG01	BORTEZOMIB PHARMINICIO	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	13,007,658 L.L
L01XG01	BORTEZOMIB SHILPA	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	9,902,420 L.L
L01XG01	BORTEZOMIB SPC	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	15,743,401 L.L
L01XG01	VELZOME	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	18,154,041 L.L
L01XG02	KYPROLIS	B	Carfilzomib - 60mg	60mg	Injectable powder for solution	L.L
L01XG02	KYPROLIS	B	Carfilzomib - 60mg	60mg	Injectable powder for solution	96,642,005 L.L
L01XG03	NINLARO	B	Ixazomib - 4mg	4mg	Capsule, hard	388,991,058 L.L
L01XG03	NINLARO	B	Ixazomib - 3mg	3mg	Capsule, hard	348,420,676 L.L

...

123

...